about
Epidermal growth factor receptor targeted nuclear delivery and high-resolution whole cell X-ray imaging of Fe3O4@TiO2 nanoparticles in cancer cells.Short peptides as biosensor transducers.Botulinum neurotoxins and botulism: a novel therapeutic approach.Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles.Challenges in design and characterization of ligand-targeted drug delivery systems.A Hybrid Peptide PTS that Facilitates Transmembrane Delivery and Its Application for the Rapid In vivo Imaging via Near-Infrared Fluorescence Imaging.Targeting and therapeutic peptides in nanomedicine for atherosclerosis.Cytotoxicity and DNA cleavage with core-shell nanocomposites functionalized by a KH domain DNA binding peptide.Design and in vitro validation of multivalent dendrimer methotrexates as a folate-targeting anticancer therapeutic.Triple Negative Breast Cancer: Nanosolutions for a Big Challenge.Atomic force microscopy probing of receptor-nanoparticle interactions for riboflavin receptor targeted gold-dendrimer nanocomposites.Synergistic targeting of cancer and associated angiogenesis using triple-targeted dual-drug silica nanoformulations for theragnostics.RAFT-derived polymer-drug conjugates: poly(hydroxypropyl methacrylamide) (HPMA)-7-ethyl-10-hydroxycamptothecin (SN-38) conjugates.Smart Nanotransformers with Unique Enzyme-Inducible Structural Changes and Drug Release PropertiesBiophysical characterization of a riboflavin-conjugated dendrimer platform for targeted drug delivery.Targeted delivery system of nanobiomaterials in anticancer therapy: from cells to clinics.Investigation into the Biological Impact of Block Size on Cathepsin S-Degradable HPMA Copolymers.Multifaceted peptide assisted one-pot synthesis of gold nanoparticles for plectin-1 targeted gemcitabine delivery in pancreatic cancer.Peptide Mediated In Vivo Tumor Targeting of Nanoparticles through Optimization in Single and Multilayer In Vitro Cell Models.
P2860
Q30571353-F26C9247-E53A-45A6-BF61-81A587C195FCQ31043462-4888C51B-C8F1-4A78-BA5E-481DBC1874C0Q34070659-9B11B1A9-54B7-4C52-943B-AEF0364684FAQ35624762-462FC79D-27FA-40BF-A7F9-D17DF9B852A9Q35972603-4EA6FED3-8617-47B5-BEF5-ED8AF7934540Q36346851-34ED7C1A-D48A-4DBE-A49A-97EA6EAEE1B3Q36661758-9DCF4ABA-68FD-4D64-BEA5-0185C816E681Q36913594-28C32564-A197-4F41-9959-13062484D7FCQ37302893-993D70FC-0549-4848-B860-76CB493CD966Q37383231-B8449B3C-83B8-42FA-926F-BB480CE4E95CQ37422972-5494C545-66FD-48B6-A54F-351809676326Q38705194-70B38F7F-BDDC-4D20-8DA7-4AE98442C578Q39302009-A6A8BC26-3EA6-486B-9A2B-A8B650C4BB32Q39432578-EBBCBEDD-9697-47EF-A9EF-0C24F053FC0EQ39764943-63F502AC-4C8F-4274-9003-87F05488273BQ41104930-75C5F0F2-BDB9-4FEE-9D98-26B2E842D84BQ41953738-9427EFA0-F0CD-4457-B810-9EAF75236FE1Q47231065-31AE06B8-7639-4CC1-B77D-C273A5D85EFDQ48637043-33708768-9859-4D89-9E63-61E1F4BB88A8Q52646682-8CD14B4C-C126-4B25-A8AE-8CDBCF6F6A72
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Peptide-mediated cancer targeting of nanoconjugates.
@en
Peptide-mediated cancer targeting of nanoconjugates.
@nl
type
label
Peptide-mediated cancer targeting of nanoconjugates.
@en
Peptide-mediated cancer targeting of nanoconjugates.
@nl
prefLabel
Peptide-mediated cancer targeting of nanoconjugates.
@en
Peptide-mediated cancer targeting of nanoconjugates.
@nl
P2860
P356
P1476
Peptide-mediated cancer targeting of nanoconjugates.
@en
P2093
Sumita Raha
P2860
P304
P356
10.1002/WNAN.121
P577
2010-11-02T00:00:00Z